Fig. 1From: Antiviral drugs arbidol and interferon alpha-1b contribute to reducing the severity of COVID-19 patients: a retrospective cohort studyDesign of the cohort analysis. Of total 462 cases, 403 adult patients in moderate illness at hospital admission were included in the main cohort studyBack to article page